Alpha 1-antitrypsin deficiency: Difference between revisions
Mazia Fatima (talk | contribs) No edit summary |
|||
(13 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]] | __NOTOC__ | ||
{{Alpha 1-antitrypsin deficiency}} | |||
{{CMG}}; {{AE}} {{Mazia}} | |||
{{SK}}: Alpha-1-deficiency; Anti-protease deficiency; | |||
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]]''' | |||
{{DiseaseDisorder infobox | | {{DiseaseDisorder infobox | | ||
Name = Alpha 1-antitrypsin deficiency | | Name = Alpha 1-antitrypsin deficiency | | ||
Line 9: | Line 15: | ||
DiseasesDB = 434 | | DiseasesDB = 434 | | ||
MedlinePlus = 000120 | | MedlinePlus = 000120 | | ||
}} | }} | ||
==[[Alpha 1-antitrypsin deficiency overview|Overview]]== | ==[[Alpha 1-antitrypsin deficiency overview|Overview]]== | ||
==[[Alpha 1-antitrypsin deficiency historical perspective|Historical Perspective]]== | ==[[Alpha 1-antitrypsin deficiency historical perspective|Historical Perspective]]== | ||
==[[Alpha 1-antitrypsin deficiency classification|Classification]]== | |||
==[[Alpha 1-antitrypsin deficiency pathophysiology|Pathophysiology]]== | ==[[Alpha 1-antitrypsin deficiency pathophysiology|Pathophysiology]]== | ||
==[[Alpha 1-antitrypsin deficiency causes|Causes]]== | |||
==[[Alpha 1-antitrypsin deficiency differential diagnosis|Differentiating Alpha 1-antitrypsin deficiency from other Diseases]]== | ==[[Alpha 1-antitrypsin deficiency differential diagnosis|Differentiating Alpha 1-antitrypsin deficiency from other Diseases]]== | ||
Line 25: | Line 31: | ||
==[[Alpha 1-antitrypsin deficiency epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Alpha 1-antitrypsin deficiency epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Alpha 1-antitrypsin deficiency natural history|Natural History, Complications and Prognosis]]== | ==[[Alpha 1-antitrypsin deficiency risk factors|Risk Factors]]== | ||
==[[Alpha 1-antitrypsin deficiency screening|Screening]]== | |||
==[[Alpha 1-antitrypsin deficiency natural history, complications, and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | ==Diagnosis== | ||
[[Alpha 1-antitrypsin deficiency history and symptoms|History and Symptoms]] | [[Alpha 1-antitrypsin deficiency physical examination|Physical Examination]] | [[Alpha 1-antitrypsin deficiency laboratory tests|Laboratory Findings]] | [[Alpha 1-antitrypsin deficiency electrocardiogram |Electrocardiogram]] | [[Alpha 1-antitrypsin deficiency | [[Alpha 1-antitrypsin deficiency history and symptoms|History and Symptoms]] | [[Alpha 1-antitrypsin deficiency physical examination|Physical Examination]] | [[Alpha 1-antitrypsin deficiency laboratory tests|Laboratory Findings]] | [[Alpha 1-antitrypsin deficiency electrocardiogram |Electrocardiogram]] | [[Alpha 1-antitrypsin deficiency x ray|X Ray]] | [[Alpha 1-antitrypsin deficiency CT|CT]] | [[Alpha 1-antitrypsin deficiency MRI|MRI]] | [[Alpha 1-antitrypsin deficiency echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Alpha 1-antitrypsin deficiency other imaging findings|Other Imaging Findings]] | [[Alpha 1-antitrypsin deficiency other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Alpha 1-antitrypsin deficiency medical therapy|Medical Therapy]] | [[Alpha 1-antitrypsin deficiency surgery|Surgery]] | [[Alpha 1-antitrypsin deficiency primary prevention|Primary Prevention]] | [[Alpha 1-antitrypsin deficiency secondary prevention|Secondary Prevention]] | [[Alpha 1-antitrypsin deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]] | |||
[[Alpha 1-antitrypsin deficiency primary prevention|Primary Prevention]] | [[Alpha 1-antitrypsin deficiency secondary prevention|Secondary Prevention]] | [[Alpha 1-antitrypsin deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]] | |||
== | ==Related Chapters== | ||
* [[COPD]] | * [[COPD]] | ||
* [[Emphysema]] | * [[Emphysema]] | ||
Line 43: | Line 49: | ||
{{Endocrine, nutritional and metabolic pathology}} | {{Endocrine, nutritional and metabolic pathology}} | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Latest revision as of 14:24, 11 January 2018
Alpha 1-antitrypsin deficiency Microchapters |
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Alpha 1-antitrypsin deficiency On the Web |
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency |
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Synonyms and keywords:: Alpha-1-deficiency; Anti-protease deficiency;
For patient information, click here Template:DiseaseDisorder infobox
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alpha 1-antitrypsin deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies